Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase NA 1Phase 1/2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 433Neoplasms 371Prostatic Neoplasms 206Lung Neoplasms 195Colorectal Neoplasms 151Motor Activity 94Uterine Cervical Neoplasms 83Pancreatic Neoplasms 78Carcinoma, Non-Small-Cell Lung 75Head and Neck Neoplasms 74Brain Neoplasms 69Ovarian Neoplasms 65Carcinoma, Hepatocellular 53Colonic Neoplasms 51Rectal Neoplasms 50Neoplasm Metastasis 50Anxiety Disorders 46Precursor Cell Lymphoblastic Leukemia-Lymphoma 45Glioblastoma 43Hematologic Neoplasms 42Depression 41Melanoma 37Glioma 37Disease 37Stomach Neoplasms 35Sarcoma 35Multiple Myeloma 34Pain 32Carcinoma, Renal Cell 32Lymphoma 31

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Adenocarcinoma, Mucinous × 90 days × Clear all
NCT05947838 2026-05-18

A Prospective Feasibility Study Using ctDNA to Tailor Neoadjuvant Chemotherapy for Patients With Colorectal or Appendiceal Adenocarcinoma

M.D. Anderson Cancer Center

Phase NA Recruiting
48 enrolled

Adenocarcinoma, Mucinous

Data powered by HemOnc (CC BY 4.0) Colophon âš¡